Back

A Proof-of-Concept Study of a Clinical Decision Support System for Vancomycin Therapeutic Monitoring

2026-03-02 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

Artificial intelligence (AI), particularly large language models (LLMs), is increasingly explored in healthcare, yet its real-world usability and safety in high-risk clinical pharmacy tasks remain uncertain. Vancomycin therapeutic drug monitoring (TDM), which requires precise pharmacokinetic calculations and context-sensitive interpretation within a narrow therapeutic window, provides a stringent test case for AI-assisted decision support. This proof-of-concept study developed and evaluated a hy...

Predicted journal destinations